IMBiologics

Website

Operator of a biotechnology company intended to invent novel treatment options for autoimmune diseases and cancer. The company offers an immunomodulatory antibody drug, an antibody-based-immune modula...

Healthcare
Suwon-si, South Korea
Founded 2020
25 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$63.7M
Last Round
N/A
Investors
+22 other investors
View all 22 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock IMBiologics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required